JSC Biocom
http://www.biocom.ru/en
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From JSC Biocom
FTC Says Three Is Not Enough: Lupin Must Divest To Acquire Gavis, Novel
Merger would leave three companies selling antibiotic doxycycline, but Gavis must still transfer its product to G&W Laboratories as a condition of $850m acquisition.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Services
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice